Danforth Center and Dow Collaborate to Develop High-Yielding Disease-Resistant Cassava Plants
News Jan 25, 2010
Researchers at the Donald Danforth Plant Science Center have entered into a research agreement with Dow AgroSciences to study how Dow's proprietary EXZACTTM Precision Technology can help improve cassava crops. As part of the collaboration, researchers at the Danforth Center will generate data demonstrating the utility of what could be an important technology in its quest to develop high-yielding and virus resistant cassava plants. Dow agreed to donate the technology, providing access to intellectual property, validated, high-quality zinc-finger reagents, and expertise through free consultation with the company's scientists.
The EXZACTTM technology, which is based on zinc finger nucleases (ZFN) allows specific and efficient addition, deletion or editing of genes at targeted locations in plant genomes. This delivers a means for engineering multi-gene stacks, editing native genes and more efficiently producing crops with enhanced plant performance and value-added traits such as improved nutrition.
Cassava is a staple food for millions of people living in developing countries. Its production, however, is limited by several constraints. The starchy storage roots have poor nutritional content and the plant is susceptible to a number of pathogens. In Africa, for instance, cassava is under threat from the virus causing Cassava Brown Streak Disease (CBSD) and Cassava Mosaic Disease (CMD). CMD alone accounts for 35 million tons of yield loss in Africa, with an estimated value of nearly USD 1 billion per year. The Danforth Center aims to develop cassava plants resistant to both CBSD and CMD.
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE